MX2019000086A - Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas. - Google Patents

Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas.

Info

Publication number
MX2019000086A
MX2019000086A MX2019000086A MX2019000086A MX2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A MX 2019000086 A MX2019000086 A MX 2019000086A
Authority
MX
Mexico
Prior art keywords
crystal form
preparation
method therefor
tetracycline compounds
substituted tetracycline
Prior art date
Application number
MX2019000086A
Other languages
English (en)
Inventor
Huang Zhenhua
Hong Mei
Jiang Chen
Original Assignee
Kbp Biosciences Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kbp Biosciences Co Ltd filed Critical Kbp Biosciences Co Ltd
Publication of MX2019000086A publication Critical patent/MX2019000086A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/54Spiro-condensed
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)

Abstract

La presente invencion pertenece al campo de la tecnologia farmaceutica, y a las formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y a un procedimiento para la preparacion del mismo; mas especificamente, la presente invencion se refiere a formas cristalinas del compuesto representado por la formula (1), a un procedimiento para la preparacion de formas cristalinas del compuesto representado por la formula (1) y al uso de dichas formas cristalinas en la fabricacion de un medicamento para el tratamiento y/o prevencion de una enfermedad infecciosa provocada por bacterias sensibles a tetraciclina y/o bacterias resistentes a tetraciclina. [Ver fórmula (1)].
MX2019000086A 2016-06-22 2017-06-22 Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas. MX2019000086A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610457261 2016-06-22
PCT/CN2017/089470 WO2017219994A1 (zh) 2016-06-22 2017-06-22 9-氨基甲基取代的四环素类化合物的晶型及其制备方法

Publications (1)

Publication Number Publication Date
MX2019000086A true MX2019000086A (es) 2019-05-02

Family

ID=60783195

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019000086A MX2019000086A (es) 2016-06-22 2017-06-22 Formas cristalinas de un compuesto de tetraciclina sustituido con 9-aminometilo y un metodo para la preparacion de las mismas.

Country Status (22)

Country Link
US (1) US10633337B2 (es)
EP (1) EP3476831B8 (es)
JP (1) JP6883593B2 (es)
KR (1) KR102205843B1 (es)
CN (1) CN109563035B (es)
AU (1) AU2017282891B2 (es)
BR (1) BR112018076726A2 (es)
CA (1) CA3028014C (es)
CL (1) CL2018003739A1 (es)
CO (1) CO2019000513A2 (es)
ES (1) ES2906885T3 (es)
IL (1) IL263868B (es)
MA (1) MA45461A (es)
MX (1) MX2019000086A (es)
MY (1) MY186900A (es)
PE (1) PE20190810A1 (es)
PH (1) PH12018502680A1 (es)
RU (2) RU2764723C2 (es)
SG (1) SG11201811499WA (es)
TW (1) TWI656116B (es)
WO (1) WO2017219994A1 (es)
ZA (1) ZA201900274B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD962414S1 (en) 2020-02-28 2022-08-30 Beijing Xiaomi Mobile Software Co., Ltd Fan
CA3179596A1 (en) * 2020-06-11 2021-12-16 Tadeusz Warchol Crystalline forms of omadacycline, methods of synthesis thereof and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064728A2 (en) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
US8252946B2 (en) * 2007-11-14 2012-08-28 Sandoz Ag Crystalline forms of tigecycline hydrochloride
EP2252579A2 (en) * 2008-01-23 2010-11-24 Sandoz AG Antibiotic compounds
TWI680117B (zh) * 2008-05-23 2019-12-21 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
CA2842838C (en) * 2011-07-26 2017-04-25 Kbp Biosciences Co., Ltd. 9-aminomethyl substituted tetracycline compounds
CN102417465B (zh) * 2011-10-27 2014-03-12 宫宁瑞 替加环素新晶型及其制备方法

Also Published As

Publication number Publication date
ZA201900274B (en) 2020-05-27
RU2764723C2 (ru) 2022-01-19
RU2022100160A (ru) 2022-03-16
IL263868A (en) 2019-01-31
JP6883593B2 (ja) 2021-06-09
CA3028014A1 (en) 2017-12-28
BR112018076726A2 (pt) 2019-04-02
IL263868B (en) 2022-08-01
EP3476831A4 (en) 2019-11-27
MA45461A (fr) 2019-05-01
EP3476831B1 (en) 2021-11-17
US20190241515A1 (en) 2019-08-08
JP2019520363A (ja) 2019-07-18
KR102205843B1 (ko) 2021-01-22
AU2017282891B2 (en) 2020-01-02
PH12018502680A1 (en) 2019-10-14
PE20190810A1 (es) 2019-06-13
ES2906885T3 (es) 2022-04-20
US10633337B2 (en) 2020-04-28
EP3476831B8 (en) 2021-12-29
CN109563035B (zh) 2021-07-20
TW201800393A (zh) 2018-01-01
MY186900A (en) 2021-08-26
CL2018003739A1 (es) 2019-04-05
RU2019101248A3 (es) 2020-07-22
TWI656116B (zh) 2019-04-11
KR20190024900A (ko) 2019-03-08
RU2019101248A (ru) 2020-07-22
CN109563035A (zh) 2019-04-02
CO2019000513A2 (es) 2019-04-30
EP3476831A1 (en) 2019-05-01
WO2017219994A1 (zh) 2017-12-28
SG11201811499WA (en) 2019-01-30
NZ749495A (en) 2020-12-18
CA3028014C (en) 2021-09-07
AU2017282891A1 (en) 2019-01-17

Similar Documents

Publication Publication Date Title
PH12016502382A1 (en) Substituted indazole compounds as irak4 inhibitors
GEP20207160B (en) New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
MX2018000396A (es) Compuestos aza sustituidos como inhibidores de cinasa 4 asociada al receptor de interleucina 1 (irak-4).
MX2022009300A (es) Derivado de quinolina muy puro y metodo para su produccion.
MY188447A (en) Indazole compounds as fger kinase inhibitor, preparation and use thereof
PH12015501881B1 (en) Amide compounds for the treatment of hiv
PH12018500061A1 (en) Oxysterols and methods of use thereof
MX2020001757A (es) Compuestos, sales de los mismos y metodos para el tratamiento de enfermedades.
EA033084B1 (ru) Бигетероарильные соединения и их применения
DOP2019000193A (es) Nuevo compuesto heterocíclico, su método de preparación y composición farmacéutica que lo comprende
PH12017500533A1 (en) 1-alkyl-6-oxo-1, 6-dihydropyridin-3-yl compounds and use as sgrm modulators
EA201991253A1 (ru) Бензодиазолиевые соединения в качестве ингибиторов enac
BR112017005242A2 (pt) composto, composição farmacêutica, e, composto para uso.
MX2016009589A (es) Enonas piridazolilo y pirimidinilo triciclicas sustituidas con arilo y arilalquilo como moduladores de la inflamacion antioxidantes.
MX2016001855A (es) Nuevos aza-oxo-indoles para el tratamiento y profilaxis de la infeccion por virus sincitial respiratorio.
MX2021012096A (es) Compuestos de indenilo, composiciones farmaceuticas y usos medicos del mismo.
MX2016002718A (es) Derivados de ceto-imidazopiridina como moduladores del receptor huerfano relacionado con receptor retinoide (porc).
MX2022006229A (es) Composiciones y metodos para el tratamiento de resistencia a la insulina.
MX2018016339A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
PH12016502568A1 (en) Novel heterocyclic compound
PH12018502680A1 (en) Crystal forms of 9-aminomethyl substituted tetracycline compound and preparation method thereof
MX2018002177A (es) Nuevo derivado de catecol y composicion farmaceutica que comprende el mismo.
SG11201803867TA (en) Sodium channel blocker
MX2015010790A (es) Derivados de anilina sustituidos con n-heteroarilo como antivirales de vhc.
PH12017501560A1 (en) Tetrahydropyranyl benzamide derivatives